載入...
Curcumin inhibits the growth of triple‐negative breast cancer cells by silencing EZH2 and restoring DLC1 expression
Enhancer of zeste homolog 2 (EZH2), an oncogene, is a commonly up‐regulated epigenetic factor in human cancer. Hepatocellular carcinoma deletion gene 1 (DLC1) is an antioncogene that is either expressed at low levels or not expressed in many malignant tumours. Curcumin is a promising anticancer drug...
Na minha lista:
| 發表在: | J Cell Mol Med |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7521266/ https://ncbi.nlm.nih.gov/pubmed/32725802 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15683 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|